Medical Disclaimer
Last Updated: April 14, 2026
⚠️ IMPORTANT: This calculator provides estimates based on clinical trial averages. Individual results vary significantly. This tool is NOT a substitute for professional medical advice. Always consult your healthcare provider before starting any weight loss medication.
1. Nature of the Calculator
The Free Semaglutide Calculator is an educational tool designed to provide approximate weight loss projections based on statistical averages derived from peer-reviewed clinical trials. The calculator uses data from the following landmark studies:
Clinical Trial Data Sources
- STEP-1 Trial (Semaglutide 2.4mg - Wegovy): A 68-week randomized, double-blind, placebo-controlled trial of 1,961 adults with obesity. Average weight loss: ~16.9% of body weight.
- SUSTAIN Trials (Semaglutide 1mg - Ozempic): Clinical trials demonstrating 10.5% average weight loss over 68 weeks at 1mg weekly dose for type 2 diabetes management.
- SURMOUNT-1 Trial (Tirzepatide 15mg - Mounjaro/Zepbound): A 72-week trial showing average weight loss of ~22.5% at the 15mg maintenance dose.
- SCALE Trial (Liraglutide 3mg - Saxenda): A 56-week trial with average weight loss of ~8% at the 3mg daily dose.
2. Individual Variability
The projections provided by this calculator are based on population-level averages. Your actual results may differ substantially due to numerous individual factors, including but not limited to:
- Biological Factors: Baseline metabolism, genetic predisposition, hormonal balance, gut microbiome composition, insulin sensitivity, and existing metabolic conditions.
- Medical History: Presence of type 2 diabetes, thyroid disorders, polycystic ovary syndrome (PCOS), sleep apnea, or other health conditions that impact weight regulation.
- Medication Adherence: Consistency in taking prescribed doses, timing of injections, proper storage of medication, and adherence to titration schedules.
- Lifestyle Factors: Dietary habits, caloric intake, macronutrient distribution, physical activity levels, sleep quality, stress management, and alcohol consumption.
- Age and Sex: Metabolic rate, muscle mass, and hormonal status vary significantly by age and biological sex.
- Starting Body Composition: Ratio of lean muscle mass to body fat, distribution of fat (visceral vs. subcutaneous), and baseline BMI.
- Concurrent Medications: Use of other medications (antidepressants, beta-blockers, corticosteroids) that may influence weight loss outcomes.
3. Not a Substitute for Medical Advice
This calculator does NOT replace the professional judgment of a licensed healthcare provider. You should:
- Consult a doctor before starting GLP-1 medications. Semaglutide, tirzepatide, and liraglutide are prescription medications with specific FDA-approved indications, contraindications, and potential side effects.
- Never self-prescribe or adjust dosages without medical supervision. Improper use of GLP-1 medications can lead to serious adverse effects.
- Discuss your complete medical history with your healthcare provider, including any history of pancreatitis, thyroid disease (especially medullary thyroid carcinoma or MEN 2), kidney disease, or diabetic retinopathy.
- Report all side effects to your doctor immediately, including nausea, vomiting, diarrhea, abdominal pain, vision changes, or signs of hypoglycemia.
4. FDA Disclaimer
The statements and projections made by this calculator have not been evaluated by the U.S. Food and Drug Administration (FDA). This tool is not intended to diagnose, treat, cure, or prevent any disease.
FDA-Approved Indications:
- Wegovy (semaglutide 2.4mg): Approved for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related condition.
- Ozempic (semaglutide 1mg): Approved for improving glycemic control in adults with type 2 diabetes. Weight loss is a secondary effect, not the primary indication.
- Mounjaro (tirzepatide 15mg): Approved for type 2 diabetes management. Weight loss is an observed effect.
- Zepbound (tirzepatide 15mg): Approved for chronic weight management in adults with obesity or overweight with weight-related conditions.
- Saxenda (liraglutide 3mg): Approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition.
5. Potential Risks and Side Effects
GLP-1 receptor agonists carry risks and potential side effects, including:
- Gastrointestinal Issues: Nausea, vomiting, diarrhea, constipation, abdominal pain, and bloating are common, especially during titration.
- Hypoglycemia: Risk of low blood sugar, particularly when combined with insulin or sulfonylureas.
- Pancreatitis: Rare but serious risk of acute pancreatitis. Seek immediate medical attention if you experience severe abdominal pain.
- Gallbladder Disease: Increased risk of gallstones and cholecystitis.
- Thyroid Tumors: Black box warning for risk of thyroid C-cell tumors (medullary thyroid carcinoma) in animal studies. Contraindicated in patients with a personal or family history of MTC or MEN 2.
- Kidney Problems: Risk of acute kidney injury, especially in patients with dehydration or pre-existing kidney disease.
- Diabetic Retinopathy: Worsening of diabetic eye disease in patients with type 2 diabetes.
6. Pregnancy and Breastfeeding
GLP-1 medications are not recommended during pregnancy or breastfeeding. If you are pregnant, planning to become pregnant, or breastfeeding, consult your healthcare provider before using any GLP-1 medication. Semaglutide and tirzepatide should be discontinued at least 2 months before a planned pregnancy.
7. No Guarantee of Weight Loss
We make no guarantees, warranties, or representations that you will achieve any specific weight loss outcome. The calculator provides estimates based on average clinical trial results, and your individual experience may differ. Some users may experience minimal weight loss or even weight gain.
8. Long-Term Maintenance Considerations
Clinical evidence suggests that discontinuing GLP-1 medications often results in weight regain. Long-term use may be required to maintain weight loss. Discuss a sustainable maintenance plan with your healthcare provider.
9. Accuracy of Calculator Inputs
The accuracy of the calculator's projections depends on the accuracy of the information you provide (current weight, goal weight, height, age, sex, activity level, medication). Inaccurate inputs will produce inaccurate projections.
10. No Doctor-Patient Relationship
Use of this calculator does not create a doctor-patient relationship between you and the operators of this website. This tool is for informational purposes only and should not replace individualized medical counseling.
11. Limitation of Liability
To the fullest extent permitted by law, the operators of Free Semaglutide Calculator shall not be liable for any health complications, adverse events, injuries, or damages resulting from:
- Reliance on the calculator's projections or recommendations
- Use of GLP-1 medications based on information from this Site
- Errors, inaccuracies, or omissions in the calculator or content
- Any medical decisions made without consulting a healthcare professional
12. Emergency Medical Situations
If you experience a medical emergency or severe side effects while using GLP-1 medications, call 911 or seek immediate medical attention. Do not rely on this website for emergency medical guidance.
13. Contact Information
If you have questions about this Medical Disclaimer, please contact us at:
Email: contact@freesemaglutidecalculator.com